Floatz logo

Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
(+)-Vincristine
Sarcoma
OHSU Knight Cancer InstituteP2B (60)
(+)-Vincristine
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
Andrew E. Place, MDP2B (60)
Vinorelbine Ditartrate
Metastatic Malignant Neoplasm In The Brain
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (60)
Vorinostat
Brain Cancer
Duke UniversityP2B (60)
Vorinostat
Non-Hodgkin Lymphoma
M.D. Anderson Cancer CenterP2B (60)
Vorinostat
B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer CenterP2B (60)
Vorolanib
Non-Small Cell Lung Carcinoma
Li-kun ChenP2B (60)
Vorolanib
Small Cell Lung Carcinoma
Henan Cancer HospitalP2B (60)
WP 1066
Glioblastoma
Northwestern UniversityP2B (60)
Yb-1
Her2-Receptor Negative Breast Cancer
University of WashingtonP2B (60)
yy-20394
B-Cell Non-Hodgkin Lymphoma
Jiangsu HengRui Medicine Co., Ltd.P2B (60)
Zanidatamab
Neoplasm
Haihua YuanP2B (60)
Zanubrutinib
Aggressive B-Cell Non-Hodgkin Lymphoma
Prelude TherapeuticsP2B (60)
Zanubrutinib
Non-Hodgkin Lymphoma
Reid Merryman, MDP2B (60)
Zanubrutinib
Large B-Cell Lymphoma
Ruijin HospitalP2B (60)
Zanubrutinib
Myelodysplastic Syndrome
Medical College of WisconsinP2B (60)
Zanubrutinib
MALT Lymphoma
SWOG Cancer Research NetworkP2B (60)
Zanubrutinib
Nodal Marginal Zone B-Cell Lymphoma
SWOG Cancer Research NetworkP2B (60)
Zanzalintinib
Clear Cell Renal Carcinoma
Kelly Fitzgerald, MDP2B (60)
Zanzalintinib
Nonpapillary Renal Cell Carcinoma
City of Hope Medical CenterP2B (60)
(Z)-Endoxifen
Breast Carcinoma
National Cancer Institute (NCI)P2B (60)
Zilovertamab Vedotin
Richter Transformation
Merck Sharp & Dohme LLCP2B (60)
zt006
Obesity Disorder
Beijing QL Biopharmaceutical Co.,LtdP2B (60)
68ga-psma
Prostate Cancer
The First Affiliated Hospital of Anhui Medical UniversityP2B (59)
Abemaciclib
Cancer
University Health Network, TorontoP2B (59)
Showing 2251 to 2275 of 13,155 assets
PreviousPage 91 of 527Next